Skip Navigation



NDT Advance Access published online on October 2, 2007

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm672
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/3/827    most recent
gfm672v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marsell, R.
Right arrow Articles by Jonsson, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsell, R.
Right arrow Articles by Jonsson, K. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Gene Expression Analysis of Kidneys From Transgenic Mice Expressing Fibroblast Growth Factor-23

Richard Marsell1, Tijana Krajisnik2, Hanna Göransson2, Claes Ohlsson3, Östen Ljunggren2, Tobias E. Larsson2 and Kenneth B. Jonsson1

1 Department of Surgical Sciences 2 Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden 3 Center for Bone Research at the Sahlgrenska Academy (CBS), Department of Internal Medicine, Gothenburg University, Gothenburg, Sweden

Correspondence and offprint requests to: Correspondence and offprint requests to: Richard Marsell, Department of Surgical Sciences, Uppsala University Hospital, Uppsala 751 85, Sweden. Fax: +46-18-50-09-52; E-mail: Richard.Marsell{at}surgsci.uu.se



  Abstract

Background. Fibroblast growth factor-23 (FGF23), a circulating protein produced in bone, causes decreased renal inorganic phosphate (Pi) reabsorption by reducing the expression of the sodium phosphate cotransporter type 2a (Npt2a). We have previously generated transgenic mice expressing human wild-type (WT) FGF23 under the control of the {alpha}1 (I) collagen promoter.

Methods. In this study, we performed a large-scale gene expression study of kidneys from FGF23 transgenic mice and WT littermates. Microarray expression data of key transcripts were verified by real-time RT-PCR analysis.

Results. Several genes that play a role in Pi regulation revealed decreased expression levels in the transgenic mice, such as Npt2a and Pdzk1, a scaffolding protein known to interact with Npt2a. Importantly, Klotho, a suggested FGF23 receptor cofactor, was the most significantly decreased transcript and {alpha}2-Na+/K+-ATPase (Atp1a2), a gene isoform of {alpha}1-Na+/K+-ATPase (Atp1a1) which has recently been shown to interact with Klotho and regulate calcium metabolism, was the most increased transcript. In contrast, other genes proposed to regulate Pi levels, such as secreted frizzled-related protein-4 (sFrp4) and Na+/H+ exchanger regulatory factor-1 (Nherf1) revealed no changes.

Conclusions. FGF23 transgenic mice display differentially expressed transcript levels of several genes essential in renal Pi regulation. These findings may lead to further understanding of how FGF23 mediates its actions on renal Pi regulation.

Keywords: Atp1a1; Atp1a2; FGF-23; Klotho; phosphate

Received for publication: 13. 7.07
Accepted in revised form: 3. 9.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Ichikawa, A. H. Sorenson, A. M. Austin, D. S. Mackenzie, T. A. Fritz, A. Moh, S. L. Hui, and M. J. Econs
Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression
Endocrinology, June 1, 2009; 150(6): 2543 - 2550.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.